|
Volumn 39, Issue 11, 2000, Pages 859-861
|
Clotrimazole troche vs. itraconazole oral solution in the treatment of oral candidosis in AIDS patients
|
Author keywords
[No Author keywords available]
|
Indexed keywords
CLOTRIMAZOLE;
ITRACONAZOLE;
ANTIFUNGAL AGENT;
ACQUIRED IMMUNE DEFICIENCY SYNDROME;
ADOLESCENT;
ADULT;
ARTICLE;
CLINICAL ARTICLE;
CLINICAL TRIAL;
COMPARATIVE STUDY;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DRUG EFFECT;
DRUG EFFICACY;
DRUG SAFETY;
FEMALE;
HUMAN;
HUMAN IMMUNODEFICIENCY VIRUS;
MALE;
OPPORTUNISTIC INFECTION;
PROSPECTIVE STUDY;
RANDOMIZED CONTROLLED TRIAL;
RELAPSE;
RESPONSE TIME;
SCORING SYSTEM;
THRUSH;
TREATMENT OUTCOME;
AIDS RELATED COMPLEX;
DOUBLE BLIND PROCEDURE;
ENZYMOLOGY;
FOLLOW UP;
HOSPITALIZATION;
LIVER;
MIDDLE AGED;
ORAL DRUG ADMINISTRATION;
PATHOLOGY;
SOLUTION AND SOLUBILITY;
TABLET;
ADMINISTRATION, ORAL;
ADOLESCENT;
ADULT;
AIDS-RELATED OPPORTUNISTIC INFECTIONS;
ANTIFUNGAL AGENTS;
CANDIDIASIS, ORAL;
CLOTRIMAZOLE;
DOUBLE-BLIND METHOD;
FEMALE;
FOLLOW-UP STUDIES;
HUMANS;
ITRACONAZOLE;
LIVER;
MALE;
MIDDLE AGED;
PROSPECTIVE STUDIES;
SEVERITY OF ILLNESS INDEX;
SOLUTIONS;
TABLETS;
TREATMENT OUTCOME;
|
EID: 0034328142
PISSN: 00119059
EISSN: None
Source Type: Journal
DOI: 10.1046/j.1365-4362.2000.00087.x Document Type: Article |
Times cited : (14)
|
References (13)
|